Related Experiment Video
Updated: Feb 5, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
Spironolactone Depletes the XPB Protein and Inhibits DNA Damage Responses in UVB-Irradiated Human Skin
Michael G Kemp1, Smita Krishnamurthy2, Michael N Kent3
1Department of Pharmacology and Toxicology, Wright State University Boonshoft School of Medicine, Dayton, Ohio, USA.
Abstract:
UVB wavelengths of light induce the formation of photoproducts in genomic DNA that are potentially mutagenic and detrimental to epidermal cell function. The mineralocorticoid and androgen receptor antagonist spironolactone (SP) was recently identified as an inhibitor of UV photoproduct removal in human cancer cells in vitro via its ability to promote the rapid proteolytic degradation of the DNA repair protein XPB. Using normal human keratinocytes in vitro and skin explants ex vivo, we found that SP rapidly depleted XPB protein in both systems and abrogated two major responses to UVB-induced DNA damage, including the removal of UV photoproducts from genomic DNA and the activation of ATR/ATM DNA damage kinase signaling. These effects were also correlated with both mutagenesis and a predisposition to UVB-induced cell death but were unique to SP, because neither the SP metabolites canrenone and 7α-thiomethylspironolactone nor the more specific mineralocorticoid receptor antagonist eplerenone affected XPB protein levels or the UVB response. Our findings provide an approach for studying XPB and its roles in the UVB DNA damage response in human skin ex vivo and indicate that SP may increase UVB mutagenesis and skin cancer risk in certain individuals.
Insights
Spironolactone (SP) hinders DNA repair by degrading the XPB protein, increasing susceptibility to UVB damage and potentially raising skin cancer risk. This highlights SP
Area of Science:
- Dermatology
- Molecular Biology
- Genetics
Background:
- Ultraviolet B (UVB) radiation causes DNA photoproducts, which are mutagenic and impair epidermal cell function.
- Spironolactone (SP), a mineralocorticoid and androgen receptor antagonist, inhibits UV photoproduct removal by promoting degradation of the DNA repair protein XPB.
Purpose of the Study:
- To investigate the effects of spironolactone (SP) on DNA repair mechanisms in human skin cells and explants.
- To determine if SP impacts the removal of UVB-induced DNA damage and subsequent cellular responses.
Main Methods:
- Experiments were conducted using normal human keratinocytes in vitro and human skin explants ex vivo.
- The study assessed XPB protein levels, UV photoproduct removal, and ATR/ATM DNA damage kinase signaling activation following UVB exposure.
Main Results:
- Spironolactone (SP) rapidly depleted XPB protein in both keratinocytes and skin explants.
- SP abrogated UV photoproduct removal and ATR/ATM kinase signaling activation in response to UVB.
- These effects correlated with increased mutagenesis and cell death, and were specific to SP, not its metabolites or eplerenone.
Conclusions:
- Spironolactone (SP) impairs UVB DNA damage response pathways by depleting XPB protein in human skin.
- SP may increase UVB-induced mutagenesis and skin cancer risk in individuals.
- This study provides a model for investigating XPB's role in skin's UVB DNA damage response.
Related Concept Videos
From DNA to Protein
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Feedback Inhibition
The Unfolded Protein Response
Regulation of the Unfolded Protein Response

